Innovation enabled by new drug discovery technologies

This is the latest episode of the free DDW narrated podcast, titled "Innovation enabled by new drug discovery technologies", which covers two articles written for DDW Volume 24 – Issue 3, Summer 2023. They are called: "CRISPR breakthroughs: New solutions for common diseases" and "Re-assessing the risks of drug-induced arrhythmias during drug discovery".  In the first article, Rolf Turk, Senior Manager, Genomics Medicine at Integrated DNA Technologies, examines how CRISPR is being used to enhance cancer therapies. In the second article, Dr Mark Treherne, Dr Jack Scannell and Dr Richard Saumarez answer the question: Can potentially lethal arrhythmias induced by novel drugs be better predicted by using more relevant and sophisticated electrophysiological screening methods?